[Internal hospital treatment of spinal and joint diseases. Experiences with a new percutaneously acting drug].
D000368:Aged; D000605:Amino Alcohols / Q000008:administration & dosage; D000893:Anti-Inflammatory Agents; D001565:Benzoates / Q000008:administration & dosage; D001593:Benzyl Compounds / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007388:Internal Medicine; D007592:Joint Diseases / Q000188:drug therapy*; D008038:Liniments; D008297:Male; D008833:Microcirculation; D008875:Middle Aged; D009539:Nicotinic Acids / Q000008:administration & dosage; D012459:Salicylates / Q000008:administration & dosage; D012869:Skin Absorption; D013122:Spinal Diseases / Q000188:drug therapy*
D000605:Amino Alcohols; D000893:Anti-Inflammatory Agents; D001565:Benzoates; D001593:Benzyl Compounds; D008038:Liniments; D009539:Nicotinic Acids; D012459:Salicylates
Zur Behandlung von Wirbelsäulen- und Gelenkerkrankungen im Bereich der inneren Klinik. Erfahrungen mit einem neuen transkutan wirksamen Therapeutikum.